Skip to main content

Advertisement

SpringerLink
Log in

Presentation, imaging, patterns of care, growth, and outcome in sporadic and von Hippel–Lindau-associated central nervous system hemangioblastomas

  • Research
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Object

Hemangioblastoma is a relatively rare neoplasm occurring mostly in the cerebellum that may arise sporadically or in the context of von Hippel–Lindau (VHL) syndrome. Presentation, imaging, natural history, surgical patterns of care, and outcomes are incompletely defined for this uncommon lesion. We reviewed our large institutional series to help clarify these issues.

Methods

Retrospective analysis of consecutive, neurosurgically managed CNS hemangioblastomas at Mayo Clinic, 1988–2018.

Results

Two hundred and eighty five hemangioblastomas were treated in 184 unique patients (115 sporadic, 69 VHL). Compared to sporadic patients, VHL patients were younger (36.7 vs 51.7 years; p < 0.0001), were treated while asymptomatic more commonly (47.3 vs 4.2%; p < 0.0001), had smaller lesions (6.6 vs 13.9 mL; p < 0.0001), and harbored lesions with associated cysts less frequently (51.0 vs 75.0%; p = 0.0002). Macrocystic tumor architecture was associated with larger lesion size and greater symptom severity. Solid lesions later formed cysts at a median 130 months. Growth in both total volume and solid component accelerated after cyst formation (10.6 and 6.0 times median rate prior to cyst emergence). VHL patients died at a younger age (47.9 vs 74.5, p = 0.0017) and were more likely to die of direct disease sequelae. Though treatment-free survival time was significantly longer in sporadic cases, a substantial fraction (> 40%) developed tumor recurrence/progression requiring additional treatment.

Conclusions

Hemangioblastoma presentation varies with etiology and clinical course is more complicated in VHL cases. Nodular lesions often develop cysts over time which is associated with accelerated tumor growth. Sporadic cases have a previously unappreciated but substantial risk of late recurrence/progression requiring treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P (1989) Hemangioblastomas of the central nervous system: a 10-year study with special reference to von Hippel–Lindau syndrome. J Neurosurg 70(1):24–30

    Article  CAS  Google Scholar 

  2. Kano H, Shuto T, Iwai Y et al (2015) Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg 122(6):1469–1478

    Article  Google Scholar 

  3. Hanakita S, Koga T, Shin M et al (2014) The long-term outcomes of radiosurgery for intracranial hemangioblastomas. Neuro Oncol 16(3):429–433

    Article  Google Scholar 

  4. Lonser RR, Glenn GM, Walther M et al (2003) von Hippel–Lindau disease. The Lancet 361(9374):2059–2067

    Article  CAS  Google Scholar 

  5. Iwai K, Yamanaka K, Kamura T et al (1999) Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96(22):12436–12441

    Article  CAS  Google Scholar 

  6. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W (1999) The von Hippel–Lindau tumor suppressor protein is a component of an E3 ubiquitin–protein ligase activity. Genes Dev 13(14):1822–1833

    Article  CAS  Google Scholar 

  7. Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel–Lindau protein. Proc Natl Acad Sci USA 93(20):10595–10599

    Article  CAS  Google Scholar 

  8. Maxwell PH, Wiesener MS, Chang G-W et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271

    Article  CAS  Google Scholar 

  9. Takayanagi S, Mukasa A, Tanaka S et al (2017) Differences in genetic and epigenetic alterations between von Hippel–Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol 19(9):1228–1236

    Article  CAS  Google Scholar 

  10. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823

    Article  Google Scholar 

  11. Sato Y, Yoshizato T, Shiraishi Y et al (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 45(8):860

    Article  CAS  Google Scholar 

  12. Maher E, Yates J, Harries R et al (1990) Clinical features and natural history of von Hippel–Lindau disease. QJM Int J Med 77(2):1151–1163

    Article  CAS  Google Scholar 

  13. Nielsen SM, Rhodes L, Blanco IG et al (2016) Von Hippel–Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome 2016. Am Soc Clin Oncol. https://doi.org/10.1200/JCO.2015.65.6140

    Article  Google Scholar 

  14. Lonser RR, Butman JA, Huntoon K et al (2014) Prospective natural history study of central nervous system hemangioblastomas in von Hippel–Lindau disease. J Neurosurg 120(5):1055–1062

    Article  Google Scholar 

  15. Knudson AG Jr (1986) Genetics of human cancer. Annu Rev Genet 20(1):231–251

    Article  Google Scholar 

  16. Knudson AG Jr, Strong LC (1972) Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24(5):514

    PubMed  PubMed Central  Google Scholar 

  17. Louis D, Ohgaki H, Wiestler O, Cavenee W (2016) WHO classification of tumours of the central nervous system (revised 4th edition). International Agency for Research on Cancer (IARC), Lyon

    Google Scholar 

  18. Pelliccia F, Limongelli G, Autore C, Gimeno-Blanes JR, Basso C, Elliott P (2019) Sex-related differences in cardiomyopathies. Int J Cardiol 286:239–243

    Article  Google Scholar 

  19. Maher ER, Neumann HP, Richard S (2011) von Hippel–Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617–623

    Article  CAS  Google Scholar 

  20. Woodward ER, Wall K, Forsyth J, Macdonald F, Maher ER (2007) VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Brain 130(3):836–842

    Article  Google Scholar 

  21. Huntoon K, Wu T, Elder JB et al (2016) Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel–Lindau disease. J Neurosurg 124(4):971–976

    Article  CAS  Google Scholar 

  22. Lonser RR, Vortmeyer AO, Butman JA et al (2005) Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58(3):392–399

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

Funding was provided by the Mayo Clinic Department of Neurological Surgery, Rochester, MN.

Author information

Authors and Affiliations

  1. Department of Neurologic Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA

    Hirokazu Takami, Christopher S. Graffeo, Avital Perry, Desmond A. Brown, Fredric B. Meyer, Terry C. Burns & Ian F. Parney

Authors
  1. Hirokazu Takami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher S. Graffeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avital Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Desmond A. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fredric B. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Terry C. Burns
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ian F. Parney
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: HT, IFP. Manuscript writing: HT. Final editing and approval of the manuscript: HT, CG, AP, DAB, FBM, TCB, IFP.

Corresponding author

Correspondence to Ian F. Parney.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takami, H., Graffeo, C.S., Perry, A. et al. Presentation, imaging, patterns of care, growth, and outcome in sporadic and von Hippel–Lindau-associated central nervous system hemangioblastomas. J Neurooncol 159, 221–231 (2022). https://doi.org/10.1007/s11060-022-04021-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-022-04021-8

Keywords

Search

Navigation